Cart
sales@molnova.com
C12-200
CAS No. 1220890-25-4
C12-200( —— )
Catalog No. M28191 CAS No. 1220890-25-4
C12-200 is a benchmark ionizable cationic lipidoid along with helper lipids. C12-200 is commonly used for mRNA delivery.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 176 | Get Quote |
|
| 10MG | 282 | Get Quote |
|
| 25MG | 480 | Get Quote |
|
| 50MG | 691 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameC12-200
-
NoteResearch use only, not for human use.
-
Brief DescriptionC12-200 is a benchmark ionizable cationic lipidoid along with helper lipids. C12-200 is commonly used for mRNA delivery.
-
DescriptionC12-200 is a benchmark ionizable cationic lipidoid along with helper lipids. C12-200 is commonly used for mRNA delivery.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCB2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1220890-25-4
-
Formula Weight1136.93
-
Molecular FormulaC70H145N5O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (87.96 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andrew John Eatherton, et al. Pyrimidine derivatives and their use as cb2 modulators. WO2004018433.
molnova catalog
related products
-
Thioacetanilide
Thioacetanilide possesses potential anti-inflammatory and analgesic activities.
-
PF-03814735
PF-03814735 is a novel, potent and reversible inhibitor of Aurora A/B with IC50of 0.8 nM/5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. Phase 1.
-
Cyclo(Pro-Trp)
Cyclo(Pro-Trp) and cyclo(Phe-Pro) show broad spectrum antibacterial properties.
